Advertisement

Topics

PubMed Journals Articles About "Global Genomics Market 2018 2022 Popularity Personalized Medicine" RSS

22:13 EDT 18th March 2019 | BioPortfolio

Global Genomics Market 2018 2022 Popularity Personalized Medicine PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Global Genomics Market 2018 2022 Popularity Personalized Medicine articles that have been published worldwide.

More Information about "Global Genomics Market 2018 2022 Popularity Personalized Medicine" on BioPortfolio

We have published hundreds of Global Genomics Market 2018 2022 Popularity Personalized Medicine news stories on BioPortfolio along with dozens of Global Genomics Market 2018 2022 Popularity Personalized Medicine Clinical Trials and PubMed Articles about Global Genomics Market 2018 2022 Popularity Personalized Medicine for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Genomics Market 2018 2022 Popularity Personalized Medicine Companies in our database. You can also find out about relevant Global Genomics Market 2018 2022 Popularity Personalized Medicine Drugs and Medications on this site too.

Showing "Global Genomics Market 2018 2022 Popularity Personalized Medicine" PubMed Articles 1–25 of 23,000+

Trends in interorganizational transactions in personalized medicine development.

Personalized medicine is an innovative concept that allows patients with a validated companion diagnosis (CoDx) to receive treatment using the most suitable drug. Currently, a major movement in the pharmaceutical industry involves the integrated use of multiple resources from external sources. To ascertain preferable interorganizational collaborations and their suitable exits, we compared the related transactions in personalized and nonpersonalized cancer drugs. We found that there were significantly more o...


Current landscape of personalized medicine adoption and implementation in Southeast Asia.

The emergence of personalized medicine (PM) has raised some tensions in healthcare systems. PM is expensive and health budgets are constrained - efficient healthcare delivery is therefore critical. Notwithstanding the cost, many countries have started to adopt this novel technology, including resource-limited Southeast Asia (SEA) countries. This study aimed to describe the status of PM adoption in SEA, highlight the challenges and to propose strategies for future development.

Using Google Trends to assess global public interest in osteoarthritis.

To evaluate global public interest in osteoarthritis by assessing changes in Internet search popularity of the disease over a 10-year period. Google Trends was used to obtain search popularity scores for the word "osteoarthritis" (OA) between January 2004 and June 2018. We also analyzed changes in search volume relative to changes in search patterns for all health topics. Search interest in OA was high relative to all other health searches over the given timeframe. Overall, searches for OA steadily decrease...


Precision in personalized prediction-based medicine.

Classroom Popularity Hierarchy Predicts Prosocial and Aggressive Popularity Norms Across the School Year.

This study examined the coevolution of prosocial and aggressive popularity norms with popularity hierarchy (asymmetries in students' popularity). Cross-lagged-panel analyses were conducted on 2,843 secondary school students (N  = 120; M  = 13.18; 51.3% girls). Popularity hierarchy predicted relative change in popularity norms over time, but not vice versa. Specifically, classrooms with few highly popular and many unpopular students increased in aggressive popularity norms at the beginning of the school ...

Why Does the Shift from "Personalized Medicine" to "Precision Health" and "Wellness Genomics" Matter?

Efforts to conceptualize the application of human genomics to health care have displayed an evolving set of translational research goals. Under , the aim was to individualize treatment and empower patients to take more responsibility for their own health. With the rise of interest in expert interpretation of multifactorial risk stratification, emphasis shifted to giving clinicians better tools and more authority to use them under the rubric of . The statistical nature of risk stratification, in turn, led to...

Longitudinal associations between popularity and aggression in Chinese middle and high school adolescents.

The longitudinal associations between popularity, overt aggression, and relational aggression were assessed in middle school and high school cohorts drawn from a large urban Northwest Chinese city. The middle school (n = 880; 13.33 years.) and high school samples (n = 841; 16.66 years.) were each followed for 2 years. In the concurrent regression analyses, overt aggression was more strongly and consistently associated with popularity than relational aggression after controlling for likability. Cross-lagged ...

Personalized therapy: the cornerstone of development in critical care medicine.

Critical therapy is a goal-directed personalized treatment according to the real-time changes of critical illness and the body's response to intervention, based on the theory of critical care medicine. The combination of a unified theoretical system and different interventional options for each patient promotes therapeutic process. The continuous completion of basic research and clinical evidence expands the basic theory of critical care medicine. At the same time, the rapid increase of bedside monitoring i...

Internationalization of Traditional/Complementary Medicine products: market entry as medicine.

Internationalization of Traditional/Complementary Medicine (T&CM) products is important for initiating and sustaining developments in this field. Particularly for traditional Chinese medicines (TCMs), the global market continues to expand due to an interest in the potential clinical benefits of traditional approaches that are largely considered lower risk and lower cost than many conventional treatments. While the benefits of internationalization hold clear advantages for the business of T&CM products, keep...

Back from the Dead. ACA Exchange Market Looking Healthy, Hale, and Competitive.

The brighter outlook for 2019 is what happens when the learning curve starts to flatten out. Remember, this market has only existed for five years. Margins over the past six months have exceeded even pre-ACA levels, and loss ratios reached new lows in the second quarter of 2018.

Soccer or Football Medicine? Global Sports Medicine for a Global Game.

A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients.

In gastric cancer, various surveillance strategies are suggested in international guidelines. The current study is intended to evaluate the current strategies and provide more personalized proposals for personalized cancer medicine.

Market and Patent Analyses of Wearables in Medicine.

Wearable medical devices (WMDs) will advance point-of-care diagnostics and therapeutics. This article analyses the market and patents for wearable devices. Activity monitors have the largest market share, and the intellectual property landscape is dominated by electronics corporations. However, the majority of these patents have not been realized in commercial products.

Perioperative cardiovascular medicine: 5 questions for 2018.

A MEDLINE search was performed from January 2017 to February 2018, and articles were selected for this update based on their significant influence on the practice of perioperative cardiovascular medicine.

Election 2018: Continuing the Fight.

As the party of medicine, TEXPAC throws its support behind candidates who understand what benefits doctors and their patients. In many cases, the real hurdles for medicine's best candidates loom not in the 2018 general election, but in primaries like the one on March 6.

Personalized Medicine and Medicinal Chemistry:Toward a legal framework in the European Union .

In the last years the fields of Medicinal Chemistry and especially the ones related to the so-called Personalized Medicine, has received a great attention. Significant investment and remarkable researches surround the matter; however, not all those promising advances are reaching patients as quickly as they should. The absence of an adequate regulatory framework could be not helping. The complete and/or massive sequencing of individual genomes faces many ethical-legal challenges. Some of them are the access...

Precision Medicine: Changing the way we think about healthcare.

Health care has changed since the decline in mortality caused by infectious diseases as well as chronic and non-contagious diseases, with a direct impact on the cost of public health and individual health care. We must now transition from traditional reactive medicine based on symptoms, diagnosis and treatment to a system that targets the disease before it occurs and, if it cannot be avoided, treats the disease in a personalized manner. Precision Medicine is that new way of thinking about medicine. In this ...

Correction to: ABM Clinical Protocol #29: Iron, Zinc, and Vitamin D Supplementation During Breastfeeding, by Sarah N. Taylor and The Academy of Breastfeeding Medicine. Breastfeed Med 2018;13(6):398-404. DOI: 10.1089/bfm.2018.29025.snt.

Towards Personalized Medicine in Bronchiolitis.

Emerging Technologies for Tissue Engineering: From Gene Editing to Personalized Medicine.

Technological innovation has been integral to the development of tissue engineering over the last 25 years. Future advances will require the next-generation of tissue engineers to embrace emerging technologies. Here, we discuss four key areas of opportunity in which technology can play a role: biological manipulation, advanced characterization, process automation and personalized medicine. This encompasses key developments in transdifferentiation, gene editing, spatially-resolved -omics and 3D bioprinting. ...

PLOS Medicine 2018 Reviewer and Editorial Board Thank You.

PLOS and the PLOS Medicine team would like to express our appreciation to the Editorial Board members, guest editors, and reviewers who participated in the manuscript assessment process for the journal in 2018.

Optimal Integration of Behavioral Medicine into Clinical Genetics and Genomics.

Clinical genetics and genomics will exert their greatest population impact by leveraging the rich knowledge of human behavior that is central to the discipline of behavioral medicine. We contend that more concerted efforts are needed to integrate these fields synergistically, and accordingly, we consider barriers and potential actions to hasten such integration.

Development and status of personalized medicine in Germany.

Medical treatment and disease prevention do not affect all people in the same way. Personalized medicine (PM) strives to take into consideration treatment-relevant differences between humans, for example, to improve the efficacy of medicines and to reduce side effects. In Germany, the number of approved active substances for which a biomarker test is obligatory or recommended before use has doubled in the past five years. Applications of drugs with a companion diagnostic test are often referred to as PM in ...

Editor's Introduction to This Issue (G&I 16:4, 2018).

Studying Tumor-ReacTive T Cells: A Personalized Organoid Model.

Recently in Cell, Dijkstra et al. (2018) introduced a tumor organoid/lymphocyte co-culture-based approach to expand and analyze tumor-specific T cell responses in a patient-specific manner. The platform is applicable for epithelial cancers and may have significant value for clinical translation of novel personalized immunotherapies.


Advertisement
Quick Search
Advertisement
Advertisement